9-Carboxymethoxymethylguanine (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "9-Carboxymethoxymethylguanine" in English language version.

refsWebsite

Global rank English rank

2^nd place

4^th place

11^th place

8^th place

36^th place

33^rd place

doi.org

Svensson JO, Barkholt L, Säwe J (March 1997). "Determination of acyclovir and its metabolite 9-carboxymethoxymethylguanine in serum and urine using solid-phase extraction and high-performance liquid chromatography". Journal of Chromatography. B, Biomedical Sciences and Applications. 690 (1–2): 363–366. doi:10.1016/S0378-4347(96)00424-0. PMID 9106067.
Helldén A, Odar-Cederlöf I, Diener P, Barkholt L, Medin C, Svensson JO, et al. (June 2003). "High serum concentrations of the acyclovir main metabolite 9-carboxymethoxymethylguanine in renal failure patients with acyclovir-related neuropsychiatric side effects: an observational study". Nephrology, Dialysis, Transplantation. 18 (6): 1135–1141. doi:10.1093/ndt/gfg119. PMID 12748346.
Helldén A, Odar-Cederlöf I, Larsson K, Fehrman-Ekholm I, Lindén T (December 2007). "Death delusion". BMJ. 335 (7633): 1305. doi:10.1136/bmj.39408.393137.BE. PMC 2151143. PMID 18156240.
Ruiz-Roso G, Gomis A, Fernández-Lucas M, Díaz-Domínguez M, Teruel-Briones JL, Quereda C (2012). "Aciclovir and valaciclovir neurotoxicity in patients with renal failure". Nefrologia. 32 (1): 114–115. doi:10.3265/Nefrologia.pre2011.Nov.11247. PMID 22294022.
Lindén T, Helldén A (2013). "Cotard's syndrome as an adverse effect of acyclovir treatment in renal failure". Journal of the Neurological Sciences. 333: e650. doi:10.1016/j.jns.2013.07.2255. S2CID 54428588.

Svensson JO, Barkholt L, Säwe J (March 1997). "Determination of acyclovir and its metabolite 9-carboxymethoxymethylguanine in serum and urine using solid-phase extraction and high-performance liquid chromatography". Journal of Chromatography. B, Biomedical Sciences and Applications. 690 (1–2): 363–366. doi:10.1016/S0378-4347(96)00424-0. PMID 9106067.
Helldén A, Odar-Cederlöf I, Diener P, Barkholt L, Medin C, Svensson JO, et al. (June 2003). "High serum concentrations of the acyclovir main metabolite 9-carboxymethoxymethylguanine in renal failure patients with acyclovir-related neuropsychiatric side effects: an observational study". Nephrology, Dialysis, Transplantation. 18 (6): 1135–1141. doi:10.1093/ndt/gfg119. PMID 12748346.
Helldén A, Odar-Cederlöf I, Larsson K, Fehrman-Ekholm I, Lindén T (December 2007). "Death delusion". BMJ. 335 (7633): 1305. doi:10.1136/bmj.39408.393137.BE. PMC 2151143. PMID 18156240.
Ruiz-Roso G, Gomis A, Fernández-Lucas M, Díaz-Domínguez M, Teruel-Briones JL, Quereda C (2012). "Aciclovir and valaciclovir neurotoxicity in patients with renal failure". Nefrologia. 32 (1): 114–115. doi:10.3265/Nefrologia.pre2011.Nov.11247. PMID 22294022.

Helldén A, Odar-Cederlöf I, Larsson K, Fehrman-Ekholm I, Lindén T (December 2007). "Death delusion". BMJ. 335 (7633): 1305. doi:10.1136/bmj.39408.393137.BE. PMC 2151143. PMID 18156240.

Lindén T, Helldén A (2013). "Cotard's syndrome as an adverse effect of acyclovir treatment in renal failure". Journal of the Neurological Sciences. 333: e650. doi:10.1016/j.jns.2013.07.2255. S2CID 54428588.